Background
Dora Sugranez received influenza and pneumococcal vaccines in her left shoulder on August 26, 2018. She reported arm pain immediately afterward and sought care within days for redness, swelling, and pain. She was diagnosed and hospitalized with cellulitis of the left upper arm. After the cellulitis improved, she continued to seek treatment for shoulder and arm pain, later receiving physical therapy, a steroid injection, and ultimately rotator cuff surgery.
Sugranez filed a Vaccine Program petition asserting a Table shoulder injury related to vaccine administration (SIRVA) claim, an off-Table causation-in-fact claim, and initially a significant-aggravation claim. She later abandoned the aggravation claim. The special master denied compensation, finding that her injury was cellulitis rather than SIRVA and that the cellulitis did not satisfy the Program’s six-month severity requirement. Sugranez sought review only of the Table-SIRVA analysis.
The Court’s Holding
Judge Bonilla upheld the special master’s factual rejection of Sugranez’s theory that she also had bursitis. The special master permissibly weighed competing expert opinions and concluded that the record supported cellulitis alone; the Court would not reweigh that evidence.
But the Court held that the special master’s SIRVA analysis may have applied the Vaccine Injury Table incorrectly by treating Sugranez’s normal range of motion shortly after vaccination as dispositive or adverse on the timing element. Under the Table, pain—not reduced range of motion—must begin within 48 hours of vaccination. Because the Court could not determine how much that legal error affected the denial, it granted review in part, vacated the decision only as to the Table-SIRVA claim, and remanded to the Office of Special Masters for 90 days of reconsideration.
Key Takeaways
- A Table-SIRVA claimant must show pain within the specified time period, but need not show reduced range of motion within that same 48-hour period.
- The Court upheld the special master’s factual determination rejecting a separate bursitis theory.
- The remand is narrow and does not decide whether Sugranez ultimately is entitled to compensation.
Why It Matters
The decision reinforces the distinction between the timing requirement for pain and the separate requirement that pain and reduced range of motion be limited to the vaccinated shoulder. Special masters may consider post-vaccination range-of-motion evidence, but cannot impose an extra requirement that reduced range of motion arise within 48 hours.
For Vaccine Program practitioners, the case underscores the importance of separating contemporaneous infection-related symptoms from later musculoskeletal symptoms while preserving evidence about when shoulder pain began.